This trial is terminated!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Pituitary Macroadenoma
and you are
between 18 and 99
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

This study is a single arm Phase II pilot trial. Patients enrolled on the trial will undergo implantation of high activity iodine-125 seeds into their pituitary adenoma. The tumor response to treatment will be monitored as well as change in visual fields, associated adverse effects, progression free survival and patient reported outcomes.

Provided treatments

  • Radiation: Iodine Implants

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01444209. The sponsor of the trial is University of Texas Southwestern Medical Center and it is looking for 2 volunteers for the current phase.
Official trial title:
Interstitial Radioactive Iodine Implants for the Treatment of Pan-invasive Pituitary Macroadenomas